Study designs: all MPD measure sets of study design type dosecoh

dosecoh = multiple dosage cohorts but no control group

Select table page: First Prev Next Last
   FILTER RESULTS BY:
Data set Clear All
Procedure / Protocol Clear All
Drug or Challenge Clear All
Panel Clear All
Sex Clear All
Data set MPD ID Procedure / Protocol Drug or Challenge Phenotype Measure Panel No. of Strains Sex Age Sample Size (Avg) Year
    Boon1 46901 body weight (none) body weight, pre-infection   [g]     dosage group:    low    medium    high inbred 18 f 6-9wks N=11 2011
    Boon1 46911 body weight influenza A (H5N1) virus change in body weight, post-infection   [%]     dosage group:    low    medium    high inbred 18 f 6-9wks N=11 2011
    Boon1 46921 health assessment influenza A (H5N1) virus survival (days to death, max 30)   [d]     dosage group:    low    medium    high inbred 18 f 6-9wks N=11 2011
    Boon1 46931 health assessment influenza A (H5N1) virus susceptibility to viral infection (0=susceptible, 1=resistant)   [designation]     dosage group:    low    medium    high inbred 18 f 6-9wks N=11 2011
    Crabbe2 15501 drug and metabolite quantification diazepam brain diazepam and metabolite concentration (30 min post-injection)   [ng/g]     8 mg/kg    16 mg/kg inbred 15 m 6-7wks N=8 1998
    Crabbe3 15810 rotarod ethanol fixed speed 3 rpm rotarod (latency to fall)   [s]     ethanol i.p. g/kg:    1    2    3 inbred 9 both 9-17wks N=4 2003
    Crabbe3 15815 rotarod ethanol fixed speed 6 rpm rotarod (latency to fall)   [s]     ethanol i.p. g/kg:    1    2    3 inbred 9 both 9-17wks N=4 2003
    Crabbe3 15820 rotarod ethanol fixed speed 10 rpm rotarod (latency to fall)   [s]     ethanol i.p. g/kg:    1    2    3 inbred 7 both 9-17wks N=3 2003
    Gould2 47101 drug and metabolite quantification nicotine plasma nicotine   [ng/mL]     acute 0.09mg dose    chronic 6.3mg dose inbred 8 m 8-12wks N=10 2011
    Gould2 47105 drug and metabolite quantification nicotine plasma cotinine   [ng/mL]     acute 0.09mg dose    chronic 6.3mg dose inbred 8 m 8-12wks N=10 2011
    Schughart3 57181 health assessment influenza A (H3N2) virus survival, post-infection   [d]     10 FFU group    2000 FFU group    200000 FFU group inbred w/CC8 8 both 7-13wks N=11 2013
    Schughart3 57191 health assessment influenza A (H3N2) virus susceptibility to viral infection (0=resistant, 1=susceptible), mortality rate   [score]     10 FFU group    2000 FFU group    200000 FFU group inbred w/CC8 8 both 7-13wks N=11 2013
    Threadgill2 39602 metabolic panel acetaminophen alanine transaminase (serum ALT)   [IU/L]     50 mg/kg    300 mg/kg inbred 5 m 6-8wks N=5 2005
    All boxes             To see more rows use the paging control at top.